Arrowstreet Capital’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-40,605
Closed -$92K 1544
2024
Q1
$92K Sell
40,605
-5,375
-12% -$12.2K ﹤0.01% 1615
2023
Q4
$135K Sell
45,980
-133,603
-74% -$392K ﹤0.01% 1363
2023
Q3
$760K Buy
+179,583
New +$760K ﹤0.01% 1048